Published in
Elsevier, Annals of Oncology, (32), p. S1313, 2021
DOI: 10.1016/j.annonc.2021.08.2115
Links
Tools
LBA38 Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types
Journal article published in 2021 by
P. Bono,
A. Minchom,
S. Shetty,
Y. T. Ma,
R. Cruz,
M. J. A. de Jonge,
C. Yap 
,
A. Pasanen,
T. Skytta,
S. M. E. Iivanainen,
L. Verlingue,
P. Jaakkola,
M. J. de Miguel,
S. Arora,
D. Graham
and other authors.
,
A. Pasanen,
T. Skytta,
S. M. E. Iivanainen,
L. Verlingue,
P. Jaakkola,
M. J. de Miguel,
S. Arora,
D. Graham
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 